Avestar Capital LLC Has $2.30 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Avestar Capital LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,675 shares of the medical equipment provider’s stock after purchasing an additional 170 shares during the quarter. Avestar Capital LLC’s holdings in Intuitive Surgical were worth $2,297,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Creekmur Asset Management LLC lifted its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC bought a new stake in Intuitive Surgical in the second quarter valued at $26,000. Godsey & Gibb Inc. raised its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. LRI Investments LLC bought a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. Finally, LGT Financial Advisors LLC boosted its position in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $539.46 on Tuesday. The firm has a market capitalization of $192.14 billion, a price-to-earnings ratio of 86.26, a P/E/G ratio of 5.39 and a beta of 1.39. The stock has a fifty day moving average of $505.63 and a 200 day moving average of $465.19. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 269 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,539 shares of company stock valued at $26,112,364 in the last quarter. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on ISRG shares. Royal Bank of Canada increased their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. BTIG Research set a $535.00 target price on Intuitive Surgical in a report on Friday, October 18th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Robert W. Baird lifted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $524.61.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.